Complementing Internal Productivity with Key External Alliances
ALTACE® ( King Pharmaceuticals)
- Marketed ACE Inhibitor with Clinically Proven Survival Benefit
FluMist™ (Aviron)
- Live, Cold-adapted Influenza Vaccine for Nasal Dosing
- BLA Filed 10/00
HCI-436 (ViroPharma)
- Small Molecule Inhibitor of Hepatitis C Replication
- In Phase II Studies
AIP-001 (Elan)
- Immunotherapeutic Approach to Alzheimer’s Disease
- Completing Phase I Studies
- Complemented by In-house Small Molecule Approach